Zdrowie i gospodarka · 18/09/2024
FDA Releases Final Guidance for Conducting Clinical Trials with Decentralized Elements
The FDA has released a final guidance document outlining recommendations for implementing decentralized elements in clinical trials for drugs, biological products, and devices, ensuring the safety and integrity of trial data and participants.